← Back to Search

Procedure

Early Chest Tube Removal for Collapsed Lung

N/A
Recruiting
Research Sponsored by Swedish Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patient undergoing video assisted thoracoscopic surgery with blebectomy/wedge resection and chemical pleurodesis for primary spontaneous pneumothorax
Be older than 18 years old
Must not have
Subjects with history of chest radiation or prior ipsilateral chest surgery
Children (<18)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years from surgery
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to determine if removing the chest tube one day after surgery is as effective as removing it two days after surgery in preventing recurrence of collapsed lung. The study will also assess if early removal of

Who is the study for?
This trial is for individuals who have had a lung collapse, known as primary spontaneous pneumothorax, and are undergoing surgery. Participants should be fit for the study before their operation and willing to follow up for 2 years with visits and phone calls.
What is being tested?
The study tests if removing the chest tube early (1 day after surgery) is as effective as the standard practice of removal on day 2. It looks at recurrence rates over two years, patient comfort, hospital stay duration, and any complications or additional treatments needed.
What are the potential side effects?
Potential side effects may include discomfort from having the chest tube in place longer or shorter than usual, risks associated with earlier removal such as lung re-collapse or fluid buildup requiring further intervention.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am having surgery for a collapsed lung using a camera and small cuts.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have had chest radiation or surgery on the same side before.
Select...
I am under 18 years old.
Select...
I am unable to make my own medical decisions.
Select...
I have interstitial lung disease.
Select...
I have tuberculosis or another infectious disease.
Select...
I have had a collapsed lung due to an injury.
Select...
I have fluid or blood in the space around my lungs.
Select...
I am immunocompromised due to conditions like neutropenia or medications like steroids.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years from surgery
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years from surgery for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Secondary study objectives
Chest Tube Duration
Complications
Need for interventions
+2 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Early Chest Tube RemovalExperimental Treatment2 Interventions
Subjects within the "Early Removal" group will have their chest tube removed on POD#1 within 24 hours from the end of the surgery.
Group II: Standard Chest Tube RemovalActive Control2 Interventions
Subjects in the "Standard Removal" group will have their chest tube kept to suction on POD#1 with removal on POD#2.

Find a Location

Who is running the clinical trial?

Swedish Medical CenterLead Sponsor
54 Previous Clinical Trials
8,294 Total Patients Enrolled
~96 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top